If it's not a shrine, it's them immortalizing the label or logo as body tattoos ... helping bring in multinational giants like Cadbury, Boehringer Ingelheim and Samsung before heading up marketing ...

More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the leading cause of ...

The state-of-the-art research and development center in Georgia will help improve the health and wellbeing of animals ...

In his new role, Abdallah will focus on advancing Boehringer Ingelheim’s strategic priorities, fostering innovation, and driving market growth across key areas of healthcare including stroke, ...

The $66 million project is part of the company's obligation made to the state after it moved here to invest a total of $120 ...

Luckily, my “manager” was played by a British-accented actor and my new ailment was also fictional ... at Ridgefield biopharma firm Boehringer Ingelheim have taken part in the same program ...

No. 49 / 2024Zealand Pharma Announces Financial Results for the First Nine Months of 2024Continued strong progress across ...

With a capital investment of $66.1 million and 63 new jobs created ... U.S. Animal Health Country Managing Director at Boehringer Ingelheim. "Each year, we invest nearly 12 percent of our sales ...

Grand Opening of State-of-the-Art Research and Development Facility "Our new research and development ... Health Country Managing Director at Boehringer Ingelheim. "Each year, we invest nearly ...

Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...

Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the oncology-focused platform company’s decision to file for bankruptcy. Notable's ...